High statistical heterogeneity is more frequent in meta-analysis of continuous than binary outcomes.
暂无分享,去创建一个
[1] W. McGuire,et al. Glutamine supplementation to prevent morbidity and mortality in preterm infants. , 2016, The Cochrane database of systematic reviews.
[2] S. Fisher,et al. Stem cell treatment for acute myocardial infarction. , 2015, The Cochrane database of systematic reviews.
[3] Paul Garner,et al. Deworming drugs for soil‐transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance , 2015, The Cochrane database of systematic reviews.
[4] Levente Kriston,et al. Dealing with clinical heterogeneity in meta‐analysis. Assumptions, methods, interpretation , 2013, International journal of methods in psychiatric research.
[5] G. Guyatt,et al. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials , 2012, Canadian Medical Association Journal.
[6] C. Reimer,et al. Fermented milk for hypertension. , 2012, The Cochrane database of systematic reviews.
[7] N. Tabet,et al. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. , 2012, The Cochrane database of systematic reviews.
[8] Gerald Gartlehner,et al. [GRADE guidelines: 7. Rating the quality of evidence - inconsistency]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.
[9] A. Bhandari,et al. Positioning for acute respiratory distress in hospitalised infants and children. , 2012, The Cochrane database of systematic reviews.
[10] D. Taylor-Robinson,et al. Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. , 2012, The Cochrane database of systematic reviews.
[11] M. Coory,et al. Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. , 2010, International journal of epidemiology.
[12] M. Brady,et al. Speech and language therapy for aphasia following stroke. , 2010, The Cochrane database of systematic reviews.
[13] D. Bennett,et al. Stratification for exploring heterogeneity in systematic reviews , 2009, Annals of Internal Medicine.
[14] Gerta Rücker,et al. Undue reliance on I2 in assessing heterogeneity may mislead , 2008, BMC medical research methodology.
[15] Julian P T Higgins,et al. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. , 2008, International journal of epidemiology.
[16] Gordon H Guyatt,et al. GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .
[17] J. Sterne,et al. Meta‒Analysis in Stata™ , 2008 .
[18] S. Brunskill,et al. Stem cell treatment for acute myocardial infarction. , 2008, The Cochrane database of systematic reviews.
[19] Tania B. Huedo-Medina,et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? , 2006, Psychological methods.
[20] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[21] Fujian Song,et al. Quality of Cochrane reviews , 2002, BMJ : British Medical Journal.
[22] F. Ducharme,et al. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. , 2002, The Cochrane database of systematic reviews.
[23] Douglas G. Altman,et al. Systematic reviews in health care : meta-analysis in context , 2008 .
[24] J. Ioannidis,et al. Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.